Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.0 to v3.5.3, indicating a minor site release rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:42.000Z thumbnail image
  2. Check
    16 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Napoli, Italy was updated to Naples, Italy in the locations list.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:11.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:48:06.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior operating-status notice along with Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:47:57.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Introduced a site-wide notice about potential information delays due to a lapse in government funding and where to check operating status. A new Revision: v3.4.1 tag was added and Revision: v3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-04T06:35:27.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.